References
P.E. Cryer, L. Axelrod, A.B. Grossman, S.R. Heller, V.M. Montori, E.R. Seaquist, F.J. Service, Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 94(3), 709–728 (2009)
American Diabetes Association, Standards of medical care in diabetes—2011. Diabetes Care 34, S11–S61 (2011)
B.M. Frier, Hypoglycaemia, ed. by G.J. Biessels, J.A. Luchsinger JA. Diabetes and the Brain, part 3, Chap 6 (Humana Press, New York, 2010)
A. Flint, A. Raben, J.E. Blundell, A. Astrup, Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int. J. Obes. Relat. Metab. Disord. 24, 38–48 (2000)
R. Chlup, J. Zapletalova, K. Peterson, I. Poljakova, E. Lenhartova, A. Tancred, R. Perera, J. Smital, Impact of buccal glucose spray, liquid sugars and dextrose tablets on the evolution of plasma glucose concentration in healthy persons. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub. 153(3), 205–209 (2009)
H. Zhang, J. Zhang, J.B. Streisand, Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin. Pharmacokinet. 41(9), 661–680 (2002)
R.R. Gunning, A.J. Garber, Bioactivity of instant glucose. Failure of absorption through oral mucosa. JAMA 240(15), 1611–1612 (1978)
T. Kimura, H. Yamano, A. Tanaka, T. Matsamura, M. Ueda, K. Ogawara, K. Higaki, Transport of d-glucose across cultured stratified cell layer of human mucosal cells. J. Pharm. Pharmacol. 54(2), 213–219 (2002)
Y. Oyama, H. Yamano, A. Ohkuma, K. Ogawara, K. Higaki, T. Kimura, Carrier-mediated transport systems for glucose in mucosal cells of the human oral cavity. J. Pharm. Sci. 88(8), 830–834 (1999)
R. Ganeshalingam, M. O’Connor, Evidence behind the WHO guidelines: hospital care for children: what is the efficacy of sublingual, oral and intravenous glucose in the treatment of hypoglycaemia? J. Trop. Pediatr. 55(5), 287–289 (2009)
Acknowledgements
This study was supported by an educational grant to the University Campus Bio-Medico by Generex Biotechnology Corporation which also provided glucose rapid spray devices this study for the trial. The sponsor had no role in the study design, data collection, data analysis or interpretation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khazrai, Y.M., Cacciapaglia, F., Palermo, A. et al. The use of a glucose spray device to control progression towards hypoglycaemia. Endocrine 42, 442–444 (2012). https://doi.org/10.1007/s12020-012-9620-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-012-9620-4